BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 11114415)

  • 21. Cottontail rabbit papillomavirus (CRPV) model system to test antiviral and immunotherapeutic strategies.
    Christensen ND
    Antivir Chem Chemother; 2005; 16(6):355-62. PubMed ID: 16331841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intralesional cidofovir for recurrent laryngeal papillomas: preliminary report.
    Wilson WR; Hashemiyoon R; Hawrych A
    Ear Nose Throat J; 2000 Apr; 79(4):236-8, 240. PubMed ID: 10786384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical cidofovir for severe cutaneous human papillomavirus and molluscum contagiosum infections in patients with HIV/AIDS. A pilot study.
    Calista D
    J Eur Acad Dermatol Venereol; 2000 Nov; 14(6):484-8. PubMed ID: 11444271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resolution of recalcitrant human papillomavirus gingival infection with topical cidofovir.
    Calista D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Dec; 90(6):713-5. PubMed ID: 11113816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections.
    De Clercq E
    Clin Microbiol Rev; 2003 Oct; 16(4):569-96. PubMed ID: 14557287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of intravitreal injections of HPMPC and related nucleoside analogues on intraocular pressure in guinea pig eyes.
    Banker AS; De Clercq E; Taskintuna I; Keefe KS; Bergeron-Lynn G; Freeman WR
    Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1233-42. PubMed ID: 9620084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. (S)-1-(3-hydroxy-2-(phosphonylmethoxy)propyl)cytosine (HPMPC): a potent antiherpesvirus agent.
    Bronson JJ; Ferrara LM; Hitchcock MJ; Ho HT; Woods KL; Ghazzouli I; Kern ER; Soike KF; Martin JC
    Adv Exp Med Biol; 1990; 278():277-83. PubMed ID: 1963042
    [No Abstract]   [Full Text] [Related]  

  • 28. A transactivator function of cottontail rabbit papillomavirus e2 is essential for tumor induction in rabbits.
    Jeckel S; Huber E; Stubenrauch F; Iftner T
    J Virol; 2002 Nov; 76(22):11209-15. PubMed ID: 12388680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical CTC-96 accelerates wart growth in rabbits infected with cottontail rabbit papillomavirus.
    Ostrow RS; Coughlin S; McGlennen RC; Liu Z; Zelterman D; Faras AJ
    Antiviral Res; 1994 May; 24(1):27-35. PubMed ID: 7944311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of phosphonylmethoxyalkyl-purine and -pyrimidine derivatives on TK+ and TK- HSV-1 keratitis in rabbits.
    Maudgal PC; De Clercq E
    Antiviral Res; 1991 Jul; 16(1):93-100. PubMed ID: 1663731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acyclic nucleoside phosphonates in the chemotherapy of DNA virus and retrovirus infections.
    De Clercq E
    Intervirology; 1997; 40(5-6):295-303. PubMed ID: 9675635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of compounds exhibiting anti-orthopoxvirus activity in animal models.
    Smee DF; Sidwell RW
    Antiviral Res; 2003 Jan; 57(1-2):41-52. PubMed ID: 12615302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
    Snoeck R; Andrei G; Gérard M; Silverman A; Hedderman A; Balzarini J; Sadzot-Delvaux C; Tricot G; Clumeck N; De Clercq E
    Clin Infect Dis; 1994 Apr; 18(4):570-8. PubMed ID: 8038312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of nucleoside phosphonates and their analogs and prodrugs for inhibition of orthopoxvirus replication.
    Keith KA; Hitchcock MJ; Lee WA; Holý A; Kern ER
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2193-8. PubMed ID: 12821467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of a bowenoid papulosis of the penis with local applications of cidofovir in a patient with acquired immunodeficiency syndrome.
    Snoeck R; Van Laethem Y; De Clercq E; De Maubeuge J; Clumeck N
    Arch Intern Med; 2001 Oct; 161(19):2382-4. PubMed ID: 11606156
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of Cidofovir (HPMPC, GS-504) against adenovirus type 5 infection in vitro and in a New Zealand rabbit ocular model.
    de Oliveira CB; Stevenson D; LaBree L; McDonnell PJ; Trousdale MD
    Antiviral Res; 1996 Jul; 31(3):165-72. PubMed ID: 8811201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphonylmethoxyalkyl purine and pyrimidine derivatives for treatment of opportunistic cytomegalovirus and herpes simplex virus infections in murine AIDS.
    De Castro LM; Kern ER; De Clercq E; Ghaffar A; Mayer EP; Vogt PE; Gangemi JD
    Antiviral Res; 1991 Jul; 16(1):101-14. PubMed ID: 1663726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A review of topical and intralesional cidofovir.
    Zabawski EJ
    Dermatol Online J; 2000 Sep; 6(1):3. PubMed ID: 11328613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cottontail rabbit papillomavirus model of high-risk HPV-induced disease.
    Brandsma JL
    Methods Mol Med; 2005; 119():217-35. PubMed ID: 16350405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-cancer agents. Will cidofovir be useful against cervical lesions?
    TreatmentUpdate; 2000 Sep; 12(6):6-7. PubMed ID: 12132464
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.